Vbi Vaccines Inc logo

Vbi Vaccines Inc Share Price (NASDAQ: VBIV)

▲

-0.13

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 6 Aug 2024

Check the interactive Vbi Vaccines Inc Stock chart to analyse performance

Vbi Vaccines Inc Key Stats

Check Vbi Vaccines Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.1329
Open
$0.086
Market Capitalization
$1.8M
Today's Volume
$29.7M
Revenue TTM
$9.4M
EBITDA
$-45.6M
Earnings Per Share (EPS)
$-3.54
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-419.59%

Global Institutional Holdings in Vbi Vaccines Inc

  • Name

    Holdings %

  • Perceptive Advisors LLC

    4.40%

  • Alyeska Investment Group, L.P.

    2.18%

  • Vanguard Group Inc

    0.64%

  • Geode Capital Management, LLC

    0.50%

  • BlackRock Inc

    0.38%

  • CAMBRIDGE Invest RESEARCH ADVISORS, INC.

    0.29%

Analyst Recommendation on Vbi Vaccines Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Vbi Vaccines Inc(by analysts ranked 0 to 5 stars)

About Vbi Vaccines Inc

VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
Organization
Vbi Vaccines Inc
Employees
131
CEO
Mr. Jeffery R. Baxter FCMA
Industry
Health Technology

Important FAQs about investing in VBIV Stock from India :

What is Vbi Vaccines Inc share price today?

Vbi Vaccines Inc share price today is as on at the close of the market. Vbi Vaccines Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Vbi Vaccines Inc share?

Vbi Vaccines Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Vbi Vaccines Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Vbi Vaccines Inc Stock (VBIV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vbi Vaccines Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vbi Vaccines Inc Shares .

What is the minimum amount required to buy Vbi Vaccines Inc Stock (VBIV) from India?

Indian investors can start investing in Vbi Vaccines Inc (VBIV) shares with as little as ₹88.2013 or $1 (as of September 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Vbi Vaccines Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025). Learn more about fractional shares .

What are the returns that Vbi Vaccines Inc has given to Indian investors in the last 5 years?

Vbi Vaccines Inc stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?